Nu Skin Enterprises (NUS) EBIT (2009 - 2026)

Nu Skin Enterprises has disclosed EBIT across 18 years of filings, most recently posting $4.0 million for Q1 2026.

• EBIT for Q1 2026 came in at $4.0 million, up 140.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $79.7 million (up 146.79% YoY), and the FY2025 annual result was $65.8 million, up 143.38% from the prior year.
• EBIT came in at $4.0 million for Q1 2026 at Nu Skin Enterprises, down from $23.2 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $52.1 million in Q1 2022 to a low of -$125.6 million in Q2 2024.
• The 5-year median for EBIT is $16.1 million (2023), against an average of $4.5 million.
• Peak annual rise in EBIT reached 169.15% in 2024, while the deepest fall reached 430.46% in 2024.
• Nu Skin Enterprises' EBIT stood at $27.5 million in 2022, then slumped by 41.5% to $16.1 million in 2023, then tumbled by 430.46% to -$53.1 million in 2024, then soared by 143.79% to $23.2 million in 2025, then slumped by 82.68% to $4.0 million in 2026.
• The last three EBIT figures came in at $4.0 million (Q1 2026), $23.2 million (Q4 2025), and $21.6 million (Q3 2025), per Business Quant data.